Non-Hodgkin's lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): Experience from the BFM trials

Annals of Oncology

Volumn 11, Issue SUPPL. 1, 2000, Pages

  Seidemann, K ^a,g   Henze, G ^b   Beck, J D ^c   Sauerbrey, A ^d   Kuhl J ^e   Mann, G ^f   Reiter, A ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b University Hospital Berlin   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d JENA UNIVERSITY HOSPITAL   (Germany)

^e UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^f ST ANNA CHILDREN S HOSPITAL   (Austria)

^g HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

AT; Ataxia teleangiectasia; Nijmegen Breakage Syndrome (NBS); Non Hodgkin's lymphoma (NHL)

Indexed keywords

ALKYLATING AGENT; EPIPODOPHYLLOTOXIN DERIVATIVE; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE;

ATAXIA TELANGIECTASIA; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; DOSE CALCULATION; DRUG INDUCED DISEASE; DRUG TOLERABILITY; FEMALE; HUMAN; INFANT; LARGE CELL LYMPHOMA; LYMPHOBLASTOMA; MALE; NIJMEGEN BREAKAGE SYNDROME; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; T CELL LYMPHOMA;

EID: 0033994079     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/11.suppl_1.S141     Document Type: Conference Paper

References (26)

1. Boder E. Ataxia-teleangiectasia: An overview. In Gatti RA, Swift M (eds): Ataxia-Teleangiectasia: Genetics, Neuropathology and Immunology of a Degenerative Disease of Childhood. New York: Alan R. Liss 1985; 1.
2. Bundey S. Clinical and genetic features of ataxia teleangiectasia. Int J Radiat Biol 1994; 66: 23.
3. Chrzanowska KH, Kleijer WJ, Krajewska-Walasek M et al. Eleven patients with microcephaly, immunodeficiency, and chromosomal instability: The Nijmegen-breakage syndrome. Am J Med Genet 1995; 57: 462.
4. Weemaes CMR, Smeets DFCM, van der Burgt CJAM. Nijmegen syndrome: A progress report. Int J Radiat Biol 61994; 6: 185.
5. Green AJ, Yates JRW, Taylor AMR et al. Severe microcephaly with normal intellectual development: The Nijmegen breakage syndrome. Arch Dis Child 1995; 73: 431.
6. Jaspers NG, Gatti RA, Baan C et al. Genetic complementation analysis of ataxia teleangiectasia and Nijmegen breakage syndrome: A survey of 50 patients. Cytogenet Cell Genet 1998; 49: 259.
7. Gatti RA, Berkel I, Boder E et al. Localization of an ataxia-teleangiectasia gene to chromosome 11q22-23. Nature 1988; 336: 577.
8. Varon R, Vissinga C, Platzer M et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 1998; 93; 467.
9. Meyn MS. Chromosome instability syndromes: Lessons for carcinogenesis. Curr Top Microbiol Immunol 1997; 221: 72.
10. Jongmans W, Vuillaume M, Chrzanowska K et al. Nijmegen breakage syndrome cells fail to induce the p53-mediated DNA damage response following exposure to ionizing radiation. Mol Cell Biol 1997; 17: 5016.
11. Peterson RDA, Funkhouser JD. Speculations on ataxia teleangiectasia: Defective regulation of the immunoglobulin gene superfamily. Immunol Today 1989; 10: 313.
12. Aurias A, Croquette MF, Nuyts JP et al. New data on clonal anomalies of chromosome 14 in ataxia teleangiectasia: Tct (14;14) and inv(14). Hum Genet 1986; 72: 22.
13. Aurias A, Dutrillaux R Probable involvement of immunoglobulin superlamily genes in most recurrent chromosomal rearrangements from ataxia teleangiectasia. Hum Genet 1986; 72: 25.
14. Morrell D, Cromartie E, Swift M. Mortality and cancer incidence in 236 patients with ataxia teleangiectasia. J Natl Cancer Inst 1986; 77: 89.
15. Spector BD, Filipovich AH, Perry GS, Kersey KS. Epidemiology of cancer in ataxia teleangiectasia. In Bridges BA. Harnden DG (eds): Ataxia Teleangiectasia a Cellular and Molecular Link between Cancer, Neuropatholgy and Immune Deficiency. Chichester, UK: Wiley 1982; 103.
16. Pippard EC, Hall AJ, Barker DJP, Bridges BA. Cancer in homozygotes and heterozygotes of ataxia-teleangiectasia and xeroderma pigmentosum in Britain. Cancer Res 1988; 48: 2929.
17. Filipovich AH, Mertens A, Robison L et al. Lymphoproliferative disorders associated with primary immunodeficiencies. In Magrath I (ed): The Non-Hodgkin's Lymphomas. London: Arnold 1997; 459.
18. Swift M, Morrell D, Massey RB, Chase CL. Incidence of cancer in 161 families affected by ataxia teleangiectasia. N Engl J Med 1991; 325: 1831.
19. Taylor AMR, Metcalfe JA, Thick J, Mak Y-F. Leukemia and lymphoma in ataxia teleangiectasia. Blood 1996; 87: 423.
20. Toledano SR, Lange BJ. Ataxia teleangiectasia and acute lymphoblastic leukemia. Cancer 1980; 45: 511.
21. Swift M, Morrell D, Cromartie E et al. The incidence and gene frequency of ataxia-teleangiectasia in the United States. Am J Hum Genet 1986; 39: 573.
22. Stansleld AG, Diebold J, Kapanci Y et al. Updated Kiel Classification for lymphomas. Lancet 1988; 1: 292.
23. Harris NL, Jaffe ES, Stein H et al. A Revised European American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1997; 84: 1361.
24. Bennett JM, Catorsky D, Daniel MT et al. Proposal for the classification of the acute leukemias. French American-British (FAB) Cooperative Groups. BrJ Heamatol 1976; 33: 451.
25. Reiter A, Schrappe M, Parwaresch R et al. Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biologic subtypes and stage a report of the Berlin Frankfurt Münster Group. J Clin Oncol 1995; 13: 359.
26. Murphy SB, Classification, staging and end results of treatment in childhood non-Hodgkin's lymphoma: Dissimilarities from lymphomas in adulls. Semin Oncol 1980; 7: 332.